The team at i-sense have been working collaboratively across institutions to develop point-of-care diagnostic tests for COVID-19.
Adapting i-sense diagnostic tools for COVID-19
The team have been adapting existing i-sense diagnostic technologies to be suitable for COVID-19. Several projects have been ongoing including ultrasensitive lateral flow based assays and the development of a rapid, isothermal and ultrasensitive platform to detect the virus without the need of qPCR.
The ultrasensitive test developed will dramatically reduce the analysis time of a viral test from one day in a centralised laboratory to 15 minutes anywhere. The team hopes to develop a cheaper, more accessible and more accurate diagnostic test compared to those already available.
Find our more here.